SCHEMBL8848722

SCHEMBL8848722

CC(C)(C)C(=O)Oc1ccc(-c2nnn(Cc3ccccc3)n2)cc1

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.65
L3MBTL1 Q9Y468 2/20 0.65
NPC1 O15118 2/20 0.65
THRB P10828 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.53
HDAC6 Q9UBN7 1/20 0.52
MAOB P27338 1/20 0.51
ALDH1A1 P00352 2/20 0.50
LMNA P02545 2/20 0.50
HTT P42858 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
ELANE P08246 1/20 0.49
KDM4E B2RXH2 1/20 0.48
POLB P06746 1/20 0.48
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
LTA4H P09960 1/20 0.47
SLC6A3 Q01959 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8848678 0.91 RAB9A (0.53) RAB9AL3MBTL1NPC1THRBSMN1; SMN2
SCHEMBL8848545 0.91 RAB9A (0.52) RAB9AL3MBTL1NPC1THRBSMN1; SMN2
SCHEMBL8848771 0.90 RAB9A (0.52) RAB9AL3MBTL1NPC1THRBSMN1; SMN2
SCHEMBL8848405 0.89 NPC1 (0.64) RAB9AL3MBTL1NPC1THRBSMN1; SMN2
SCHEMBL8848732 0.89 RAB9A (0.51) RAB9AL3MBTL1NPC1THRBSMN1; SMN2
SCHEMBL8848839 0.88 HDAC6 (0.60) RAB9AL3MBTL1NPC1THRBSMN1; SMN2
SCHEMBL8848741 0.88 MAOB (0.52) RAB9AL3MBTL1NPC1MAOBELANE
SCHEMBL8848554 0.88 RAB9A (0.50) RAB9AL3MBTL1NPC1THRBSMN1; SMN2
SCHEMBL8849417 0.88 MEN1 (0.61) RAB9AL3MBTL1NPC1SMN1; SMN2HDAC6
SCHEMBL8848821 0.87 HDAC6 (0.54) RAB9AL3MBTL1NPC1THRBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5602161-A ELASTASE INHIBITORS; PREVENTING AND TREATING EMPHYSEMA, ENDOTOXIN-INDUCED LUNG DISORDERS WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) 1997-02-11 US disclosed
EP-0676396-A1 Tetrazolylphenyl pivalate derivatives and medicinal composition containing the same as effective component Wakamoto Pharmaceutical Co., Ltd. (JP) 1995-10-11 EP disclosed